Vascular Breakthroughs — research payments reported

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$75,852	7
2024	Research	$184,726	15
2023	Research	$100	2
2022	Research	$200	1
2021	Research	$2,203	2
2020	Research	$40,383	9
2019	Research	$38,038	11

Breakdown

Who paid Research payments · program years 2019–2025

M.A. Med Alliance S.A. $243,945 13 payments
Boston Scientific Corporation $68,670 26 payments
TriReme Medical LLC $18,210 2 payments
Veryan Medical Incorporated $10,677 6 payments

Studies the money was for Research payments · program years 2019–2025

A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Efficacy of the SELUTION SLR 018 Drug Eluting Balloon in the Treatment of Subjects With Femoropopliteal Artery Lesions $114,974 6 payments
A Prospective Randomized Multicenter Single Blinded Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Below-the-Knee (BTK) Atherosclerotic Disease in Patients With Chronic Limb Threatening Ischemia (CLTI) $105,101 6 payments
Virtus $34,847 7 payments
Ranger II Sfa $33,823 19 payments
A Prospective Randomized Single Blind Multicenter Study to Assess the Safety and Effectiveness of the SELUTION SLR 014 Drug Eluting Balloon in the Treatment of Subjects With In-stent Restenosis $23,870 1 payment
Balloon Catheter $18,210 2 payments
A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of peripheral arterial disease: MIMICS-3D-USA $10,677 6 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.